- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Aridis Pharmaceuticals is a biotechnology business based in the US. Aridis Pharmaceuticals shares (ARDS) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $0.00 – a decrease of 50% over the previous week. Aridis Pharmaceuticals employs 37 staff and has a trailing 12-month revenue of around $22.4 million.
Our top picks for where to buy Aridis Pharmaceuticals stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Aridis Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ARDS. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Aridis Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 5 of 5
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Aridis Pharmaceuticals stock price (PINK: ARDS)
Use our graph to track the performance of ARDS stocks over time.Aridis Pharmaceuticals shares at a glance
Information last updated 2024-11-20.
| Latest market close | $0.00 |
|---|---|
| 52-week range | $0.00 - $0.09 |
| 50-day moving average | $0.00 |
| 200-day moving average | $0.04 |
| Wall St. target price | $2.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.16 |
Aridis Pharmaceuticals price performance over time
Historical closes compared with the close of $0.0001 from 2024-12-13
| 1 week (2024-12-09) | -50.00% |
|---|---|
| 1 month (2024-11-15) | 0.0001 |
| 3 months (2024-09-16) | -90.00% |
| 6 months (2024-06-14) | -99.83% |
| 1 year (2023-12-15) | -99.84% |
|---|---|
| 2 years (2022-12-16) | -99.99% |
| 3 years (2021-12-16) | 2 |
| 5 years (2019-12-16) | 4.5 |
Aridis Pharmaceuticals financials
| Revenue TTM | $22.4 million |
|---|---|
| Gross profit TTM | $-22,605,000 |
| Return on assets TTM | -4.4% |
| Return on equity TTM | 0% |
| Profit margin | -5.11% |
| Book value | $-0.27 |
| Market Capitalization | $4,457 |
TTM: trailing 12 months
Aridis Pharmaceuticals share dividends
We're not expecting Aridis Pharmaceuticals to pay a dividend over the next 12 months.
Aridis Pharmaceuticals share price volatility
Over the last 12 months, Aridis Pharmaceuticals's shares have ranged in value from as little as $0.0001 up to $0.093. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Aridis Pharmaceuticals's is -26.035. This would suggest that Aridis Pharmaceuticals's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Aridis Pharmaceuticals has bucked the trend.
Aridis Pharmaceuticals overview
Aridis Pharmaceuticals, Inc. , a late-stage biopharmaceutical company, discovers and develops targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that has completed Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin, as well as developing AR-301 as an adjunctive therapy with SOC antibiotics to treat hospital acquired pneumonia and ventilator associated pneumonia. The company is also developing AR-320, a fully human IgG1 monoclonal antibody targeting S. aureus alpha toxin to treat infections caused by methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus; AR 501, an inhaled gallium citrate, which is in Phase 1/2a for the treatment of chronic lung infection associated with cystic fibrosis; and AR-101, a human IgM mAb, which is in Phase II clinical trials targeting Pseudomonas aeruginosa liposaccharides serotype O11.
Frequently asked questions
What percentage of Aridis Pharmaceuticals is owned by insiders or institutions?Currently 18.046% of Aridis Pharmaceuticals shares are held by insiders and 10.379% by institutions. How many people work for Aridis Pharmaceuticals?
Latest data suggests 37 work at Aridis Pharmaceuticals. When does the fiscal year end for Aridis Pharmaceuticals?
Aridis Pharmaceuticals's fiscal year ends in December. Where is Aridis Pharmaceuticals based?
Aridis Pharmaceuticals's address is: 983 University Avenue, Los Gatos, CA, United States, 95032 What is Aridis Pharmaceuticals's ISIN number?
Aridis Pharmaceuticals's international securities identification number is: US0403341045 What is Aridis Pharmaceuticals's CUSIP number?
Aridis Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 040334104
More resources on Finder
More guides on Finder
-
How to buy Merck-and-Company stock (MRK)
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Intuitive Surgical stock (ISRG)
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
-
How to buy Vertex Pharmaceuticals stock (VRTX)
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
-
How to buy McKesson Corporation stock (MCK)
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Amgen stock (AMGN)
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
-
How to buy Abbott Laboratories stock (ABT)
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question